The economic burden of advanced gastric cancer in Taiwan

by Jihyung Hong, Yiling Tsai, Diego Novick, Frank Chi-huang Hsiao, Rebecca Cheng, Jen-Shi Chen
Published 2017-09-01

Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management

by Pei-Han Kao, Jen-Shi Chen, Wen-Hung Chung, Rosaline Chung-Yee Hui, Chih-Hsun Yang
Published 2015-12-01

A Nomogram Predicting Progression Free Survival in Patients with Gastrointestinal Stromal Tumor Receiving Sunitinib: Incorporating Pre-Treatment and Post-Treatment Parameters

by Yau-Ren Chang, Wen-Kuan Huang, Shang-Yu Wang, Chiao-En Wu, Jen-Shi Chen, Chun-Nan Yeh
Published 2021-05-01

Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative Chemotherapy

by Yu-Shin Hung, Jen-Shi Chen, Yen-Yang Chen, Chang-Hsien Lu, Pei-Hung Chang, Wen-Chi Chou
Published 2018-11-01

Factors related to patient propensity to receive adjuvant chemotherapy and outcomes in stage III gastric cancer cases after D2 surgery

by Jen-Shi Chen, Chia-Yen Hung, Keng-Hao Liu, Chun-Yi Tsai, Yung-Chia Kuo, Jun-Te Hsu, Wen-Chi Chou
Published 2019-05-01

Factors associated with distinct prognostic‐awareness‐transition patterns over cancer patients’ last 6 months of life

by Chen Hsiu Chen, Fur‐Hsing Wen, Wen‐Chi Chou, Jen‐Shi Chen, Wen‐Cheng Chang, Chia‐Hsun Hsieh, Siew Tzuh Tang
Published 2021-11-01

Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: A review when cardiology meets immuno-oncology

by Dong-Yi Chen, Wen-Kuan Huang, Victor Chien-Chia Wu, Wen-Cheng Chang, Jen-Shi Chen, Cheng-Keng Chuang, Pao-Hsien Chu
Published 2020-10-01

Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experienc...

by Chiao-En Wu, Wen-Chi Chou, Chia-Hsun Hsieh, John Wen-Cheng Chang, Cheng-Yu Lin, Chun-Nan Yeh, Jen-Shi Chen
Published 2020-05-01

WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells

by Chiao-En Wu, Chen-Yang Huang, Chiao-Ping Chen, Yi-Ru Pan, John Wen-Cheng Chang, Jen-Shi Chen, Chun-Nan Yeh, John Lunec
Published 2021-07-01

Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Development of a Prognostic Model

by Ching-Fu Chang, Pei-Wei Huang, Jen-Shi Chen, Yen-Yang Chen, Chang-Hsien Lu, Pei-Hung Chang, Yu-Shin Hung, Wen-Chi Chou
Published 2019-01-01

Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and On...

by Shang-Yu Wang, Chiao-En Wu, Chun-Chi Lai, Jen-Shi Chen, Chun-Yi Tsai, Chi-Tung Cheng, Ta-Sen Yeh, Chun-Nan Yeh
Published 2019-03-01

Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy

by Chiao-En Wu, Wen-Kuan Huang, Wen-Chi Chou, Chia-Hsun Hsieh, John Wen-Cheng Chang, Cheng-Yu Lin, Chun-Nan Yeh, Jen-Shi Chen
Published 2021-06-01

Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset

by Jen-Shi Chen, Chia-Yen Hung, Hung Chang, Chien-Ting Liu, Yen-Yang Chen, Chang-Hsien Lu, Pei-Hung Chang, Yu-Shin Hung, Wen-Chi Chou
Published 2018-12-01

Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone

by Ruo-Yi Huang, Hao-Wei Kou, Puo-Hsien Le, Chia-Jung Kuo, Tsung-Hsing Chen, Shang-Yu Wang, Jen-Shi Chen, Ta-Sen Yeh, Jun-Te Hsu
Published 2022-04-01

Fractioned Dose Regimen of Sunitinib for Patients with Gastrointestinal Stromal Tumor: A Pharmacokinetic and Treatment Efficacy Study

by Yen-Yang Chen, Chun-Nan Yeh, Chi-Tung Cheng, Chao-En Wu, Kun-Chun Chiang, Tsung-Wen Chen, Chih-Chi Wang, Jen-Shi Chen, Ta-Sen Yeh
Published 2014-10-01

Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis

by Chiao-En Wu, Da-Wei Yeh, Yi-Ru Pan, Wen-Kuan Huang, Ming-Huang Chen, John Wen-Cheng Chang, Jen-Shi Chen, Yu-Chao Wang, Chun-Nan Yeh
Published 2020-11-01

Risk of cardiovascular disease among different fluoropyrimidine-based chemotherapy regimens as adjuvant treatment for resected colorectal cancer

by Wen-Kuan Huang, Wen-Kuan Huang, Wei-Pang Ho, Wei-Pang Ho, Hung-Chih Hsu, Hung-Chih Hsu, Shu-Hao Chang, Dong-Yi Chen, Dong-Yi Chen, Wen-Chi Chou, Wen-Chi Chou, Pei-Hung Chang, Pei-Hung Chang, Jen-Shi Chen, Jen-Shi Chen, Tsai-Sheng Yang, Tsai-Sheng Yang, Lai-Chu See, Lai-Chu See, Lai-Chu See
Published 2022-08-01

Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in Stage III Colon Cancer: A Controlled Interrupted Time Series Analysis

by Wen-Kuan Huang, Wen-Kuan Huang, Wen-Kuan Huang, Hung-Chih Hsu, Hung-Chih Hsu, Shu-Hao Chang, Wen-Chi Chou, Wen-Chi Chou, Pei-Hung Chang, Pei-Hung Chang, Sum-Fu Chiang, John Wen-Cheng Chang, John Wen-Cheng Chang, Jen-Shi Chen, Jen-Shi Chen, Tsai-Sheng Yang, Tsai-Sheng Yang, Lai-Chu See, Lai-Chu See, Lai-Chu See
Published 2021-06-01

Modified biweekly oxaliplatin and capecitabine for advanced gastric cancer: A retrospective analysis from a medical center

by Yung-Chia Kuo, Hao-Tien Liu, Yi-Lun Lin, Yi-Chun Yang, Tsai-Sheng Yang, Chi-Ting Liau, Wen-Chi Shen, Hung-Chih Hsu, Wen-Chi Chou, Jen-Shi Chen
Published 2014-06-01

Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection—A Double Blind, Multi-Center, Randomized Ph...

by Cheng-Hsu Wang, Cheng-Yao Lin, Jen-Shi Chen, Ching-Liang Ho, Kun-Ming Rau, Jo-Ting Tsai, Cheng-Shyong Chang, Su-Peng Yeh, Chieh-Fang Cheng, Yuen-Liang Lai
Published 2019-01-01